APP and Alzheimer disease: The current study found that 6D11 has a therapeutic effect in APP/PS1 double transgenic AD mouse model and Aβ‐induced AD cell model that is exerted via increased neurogenesis and cell differentiation by transduction of Aβ peptide signal.